Context Therapeutics Inc CNTX:NASDAQ

RT Quote | USD
Last | 05/01/24 EDT
1.36quote price arrow up+0.02 (+1.16%)
Volume
37,155
52 week range
0.47 - 1.69
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.34
  • 52 Week High1.69
  • 52 Week High Date07/03/23
  • 52 Week Low0.47
  • 52 Week Low Date05/15/23

Key Stats

  • Market Cap21.714M
  • Shares Out15.97M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta2.17
  • YTD % Change20.35

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.34
  • 52 Week High1.69
  • 52 Week High Date07/03/23
  • 52 Week Low0.47
  • 52 Week Low Date05/15/23
  • Market Cap21.714M
  • Shares Out15.97M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta2.17
  • YTD % Change20.35

RATIOS/PROFITABILITY

  • EPS (TTM)-1.50
  • P/E (TTM)-0.91
  • Fwd P/E (NTM)-1.11
  • EBITDA (TTM)-25.061M
  • ROE (TTM)-102.79%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/10/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Context Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Context Therapeutics Inc. is a biopharmaceutical company advancing medicines for solid tumors. The Company is developing CTIM-76, a selective Claudin 6 (CLDN6) x CD3 bispecific antibody for CLDN6-positive tumors, which is in preclinical development. CLDN6 is a tight junction membrane protein target expressed in multiple solid tumors, including ovarian, endometrial, testicular, and lung, and absent from or expressed at low levels in healthy adult tissues. CTIM-76 is capable of...
Richard Berman
Independent Chairman of the Board
Martin Lehr
President, Chief Executive Officer, Director
Jennifer Minai-Azary
Chief Financial Officer, Treasurer
Priya Marreddy
Vice President - Clinical Operations
Address
2001 Market Street, Suite 3915 Unit #15
Philadelphia, PA
19103
United States

Top Peers

SYMBOLLASTCHG%CHG
PYPD
PolyPid Ltd
5.00+0.23+4.78%
LSTA
Lisata Therapeutics Inc
2.85+0.12+4.51%
RNXT
RenovoRx Inc
1.21UNCHUNCH
AIM
AIM ImmunoTech Inc
0.39-0.0185-4.5288%
ADXS
Ayala Pharmaceuticals Inc
0.6431UNCHUNCH